Erratum: BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203
J Clin Oncol
.
2025 Sep;43(25):2840.
doi: 10.1200/JCO-25-01680.
Epub 2025 Jul 24.
Authors
Iván Márquez-Rodas
,
Caroline Dutriaux
,
Philippe Saiag
,
Luis de la Cruz Merino
,
Eduardo Castañón Álvarez
,
Caroline Robert
,
Juan F Rodríguez-Moreno
,
Ana Arance
,
Pablo Cerezuela-Fuentes
,
Henri Montaudié
,
Miguel F Sanmamed
,
María González-Cao
,
Julie Charles
,
María Pilar López Criado
,
Alfonso Berrocal
,
Enrique de Miguel
,
Elisa Funck-Brentano
,
Sorilla Prey
,
Mᵃ Carmen Álamo de la Gala
,
Ignacio Melero
,
Jose Antonio Avilés-Izquierdo
,
Ruth Roman
,
Beatriz Garcia-Pelaez
,
Sonia Rodriguez
,
Zuzana Jirakova Trnkova
,
Marisol Quintero
,
Sonia Maciá
,
Marya F Chaney
,
Stephane Dalle
PMID:
40706004
DOI:
10.1200/JCO-25-01680
No abstract available
Publication types
Published Erratum